---

$3.50

+0.0200 ( +0.58% ) 1.3K

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-14	Buy	3442341.00	Chudnovsky Yekaterina
2024-07-02	Buy	1600000.00	Chudnovsky Yekaterina
2024-07-02	Buy	50000.00	Venkatesan Jay
2024-03-20	Buy	1032702.00	Chudnovsky Yekaterina
2024-02-05	Sale	-28200.00	Haqq Christopher
2024-02-05	Sale	-29800.00	DeMuth Peter
2024-02-05	Sale	-225137.00	Connelly Robert
2024-02-05	Sale	-43225.00	Piekos Brian
2023-12-29	Sale	-4100.00	Chudnovsky Yekaterina
2023-12-29	Sale	-4100.00	WILSON KAREN J